Skip to Main Content
HBS Home
  • About
  • Academic Programs
  • Alumni
  • Faculty & Research
  • Baker Library
  • Giving
  • Harvard Business Review
  • Initiatives
  • News
  • Recruit
  • Map / Directions
Faculty & Research
  • Faculty
  • Research
  • Featured Topics
  • Academic Units
  • …→
  • Harvard Business School→
  • Faculty & Research→
  • Research
    • Research
    • Publications
    • Global Research Centers
    • Case Development
    • Initiatives & Projects
    • Research Services
    • Seminars & Conferences
    →
  • Publications→

Publications

Publications

Filter Results: (4,834) Arrow Down
Filter Results: (4,834) Arrow Down Arrow Up

Show Results For

  • All HBS Web  (4,834)
    • People  (16)
    • News  (1,900)
    • Research  (2,361)
    • Events  (2)
    • Multimedia  (222)
  • Faculty Publications  (1,869)

Show Results For

  • All HBS Web  (4,834)
    • People  (16)
    • News  (1,900)
    • Research  (2,361)
    • Events  (2)
    • Multimedia  (222)
  • Faculty Publications  (1,869)
← Page 105 of 4,834 Results →

    Kym Lew Nelson

    Kym Lew Nelson joined the NOM unit of the Harvard Business School as a Visiting Lecturer in January of 2020. In July of 2020, she became a Senior Lecturer in the Negotiations unit. Prior to joining the faculty, Kym was a guest lecturer in the Negotiations class at... View Details

    • 2020
    • Working Paper

    The Impact of CEOs in the Public Sector: Evidence from the English NHS

    By: Katharina Janke, Carol Propper and Raffaella Sadun
    Abstract Governments worldwide have sought to reform the delivery of public services by mimicking private sector governance models that grant CEOs greater autonomy and give them responsibility for meeting key government targets. We examine the effectiveness of this... View Details
    Keywords: CEOs; Management; Performance; Public Sector; Measurement and Metrics; Health Industry
    Citation
    Read Now
    Related
    Janke, Katharina, Carol Propper, and Raffaella Sadun. "The Impact of CEOs in the Public Sector: Evidence from the English NHS." Harvard Business School Working Paper, No. 18-075, March 2018. (Revised September 2020.)
    • 07 Feb 2019
    • News

    Business Management in the Cardiac Cath Laboratory

    • 14 Aug 2014
    • News

    US-China teamwork could mean a win-win-win for Africa

    • Program

    Program for Leadership Development

    the careful selection of living group members and new HBS case studies to professional executive coaching for individuals and teams, every aspect is designed to foster collaborative learning and accelerate personal growth. Review Our... View Details
    • 16 Jul 2021
    • News

    What Ever Happened to IBM’s Watson?

    • November 2001 (Revised September 2004)
    • Case

    Evolution of Treatment, The: The Case of Diabetes

    By: Richard M.J. Bohmer, Jeffrey D. Street and Laura Feldman
    Scientific knowledge surrounding diabetes mellitus has grown over the last century to include its cause, treatment, and prevention strategies. However, the type and level of care that patients receive is suboptional. This case examines the forces in industry,... View Details
    Keywords: Policy; Health Care and Treatment; Innovation and Management; Knowledge Use and Leverage; Management; Management Analysis, Tools, and Techniques; Health Industry
    Citation
    Educators
    Purchase
    Related
    Bohmer, Richard M.J., Jeffrey D. Street, and Laura Feldman. "Evolution of Treatment, The: The Case of Diabetes." Harvard Business School Case 302-023, November 2001. (Revised September 2004.)
    • 21 Jan 2021
    • Blog Post

    How I Used the HBS Community to Hone My Professional Goals

    development rotational program. My time at Cardinal Health exposed me to the health care world and gave me the chance to work functionally in Corporate Finance and Corporate... View Details
    • October 2023
    • Article

    What Does the Inflation Reduction Act Mean for Patients and Physicians?

    By: Amitabh Chandra and Benedic Ippolito
    The debate around prescription drug measures in the recently passed U.S. Inflation Reduction Act (IRA), which limit some patients’ out-of-pocket costs, has not fully addressed their effect on physicians and patients via their effect on payers. Reducing patients’ costs... View Details
    Keywords: Government Legislation; Price; Health Care and Treatment
    Citation
    Find at Harvard
    Purchase
    Related
    Chandra, Amitabh, and Benedic Ippolito. "What Does the Inflation Reduction Act Mean for Patients and Physicians?" NEJM Catalyst Innovations in Care Delivery 4, no. 10 (October 2023).
    • 19 Mar 2018
    • News

    Those coupons people use for expensive meds are starting to count for less

    • Article

    Paradise Lost (and Restored?): A Study of Psychological Safety over Time

    By: Derrick P. Bransby, Michaela Kerrissey and Amy C. Edmondson
    Although prior research indicates that psychological safety can fluctuate, questions about when and why remain. To gain insights into the emergence and temporal dynamics of psychological safety, we explored longitudinal data representing more than 10,000 health care... View Details
    Keywords: Analytics and Data Science; Research; Attitudes; Working Conditions; Well-being; Health Industry
    Citation
    Find at Harvard
    Purchase
    Related
    Bransby, Derrick P., Michaela Kerrissey, and Amy C. Edmondson. "Paradise Lost (and Restored?): A Study of Psychological Safety over Time." Academy of Management Discoveries (in press). (Pre-published online March 14, 2024.)
    • Article

    Regulatory, Legal, and Market Aspects of Smart Wearables for Cardiac Monitoring

    By: Jan Benedikt Brönneke, Jennifer Müller, Konstantinos Mouratis, Julia Hagen and Ariel Dora Stern
    In the area of cardiac monitoring, the use of digitally driven technologies is on the rise. While the development of medical products is advancing rapidly, allowing for new use-cases in cardiac monitoring and other areas, regulatory and legal requirements that govern... View Details
    Keywords: Wearables; Regulatory Changes; Medical Technology; Medical Devices; Market Access; Market Entry and Exit; Information Technology; Health Care and Treatment; Governing Rules, Regulations, and Reforms; United States; Germany; Belgium
    Citation
    Read Now
    Related
    Brönneke, Jan Benedikt, Jennifer Müller, Konstantinos Mouratis, Julia Hagen, and Ariel Dora Stern. "Regulatory, Legal, and Market Aspects of Smart Wearables for Cardiac Monitoring." Art. 4937. Sensors 21, no. 14 (July 2021).
    • 30 Aug 2011
    • First Look

    First Look: August 30

    customers in the East, emerging markets, and growing interest in health and beauty care among men all over the world. Employing both traditional and innovative marketing techniques, L'Oréal worked to double... View Details
    Keywords: Sean Silverthorne
    • 19 May 2015
    • First Look

    First Look: May 19

    surrounding growth of a nonprofit institution and the United Kingdom's socialized health care system. Purchase this case: https://cb.hbsp.harvard.edu/cbmp/product/315012-PDF-ENG Harvard Business School Case... View Details
    Keywords: Sean Silverthorne
    • 29 Jun 2020
    • News

    After saving his own life with a repurposed drug, a professor reviews every drug being tried against Covid-19. Here's what he's found

    • 01 Apr 2014
    • News

    ‘Management by Walking Around’ programs in hospitals may do more harm than good

    • 17 Feb 2015
    • News

    An afternoon with Michael Porter

    • 19 Dec 2023
    • Research & Ideas

    $15 Billion in Five Years: What Data Tells Us About MacKenzie Scott’s Philanthropy

    comparison group. Top causes: education and health care Between 2020 and 2022, nonprofits in the youth, philanthropy, and housing sectors represented a larger share of grantees compared with the size of... View Details
    Keywords: by Matthew Lee, Brian Trelstad, and Ethan Tran
    • June 2004
    • Case

    Medical Technology Industry and Japan (A), The

    In a five-year effort, the Health Industry Manufacturers Association (HIMA) tried to influence government health policy in Japan. In 1993, HIMA mobilized in response to fears the Japanese government was planning to target the U.S. medical devices industry. The case... View Details
    Keywords: Health Care and Treatment; Policy; Globalized Markets and Industries; Government and Politics; Medical Devices and Supplies Industry; Japan; United States
    Citation
    Educators
    Purchase
    Related
    Watkins, Michael D., and Terri Zavada. "Medical Technology Industry and Japan (A), The." Harvard Business School Case 904-018, June 2004.
    • March 2012
    • Article

    Macroeconomic Policy and U.S. Competitiveness

    By: Richard H.K. Vietor and Matthew Weinzierl
    The United States is on a glide path to fiscal disaster, with experts projecting that the federal government will take in far less money than it spends-indefinitely. Our current fiscal policy is eroding competitiveness in several ways, and business conditions in the... View Details
    Keywords: Macroeconomics; Government and Politics; Financial Crisis; Policy; Competition; Public Administration Industry; United States
    Citation
    Purchase
    Related
    Vietor, Richard H.K., and Matthew Weinzierl. "Macroeconomic Policy and U.S. Competitiveness." Harvard Business Review 90, no. 3 (March 2012).
    • ←
    • 105
    • 106
    • …
    • 241
    • 242
    • →
    ǁ
    Campus Map
    Harvard Business School
    Soldiers Field
    Boston, MA 02163
    →Map & Directions
    →More Contact Information
    • Make a Gift
    • Site Map
    • Jobs
    • Harvard University
    • Trademarks
    • Policies
    • Accessibility
    • Digital Accessibility
    Copyright © President & Fellows of Harvard College.